Phase II study of sequential triplet chemotherapy, irinotecan and cisplatin followed by amrubicin, in patients with extensive-stage small cell lung cancer: West Japan Thoracic Oncology Group Study 0301. (Q33389628)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of sequential triplet chemotherapy, irinotecan and cisplatin followed by amrubicin, in patients with extensive-stage small cell lung cancer: West Japan Thoracic Oncology Group Study 0301. |
scientific article |
Statements
1 reference
Phase II study of sequential triplet chemotherapy, irinotecan and cisplatin followed by amrubicin, in patients with extensive-stage small cell lung cancer: West Japan Thoracic Oncology Group Study 0301. (English)
1 reference
Masashi Kobayashi
1 reference
Kaoru Matsui
1 reference
Yasuo Iwamoto
1 reference
Noriyuki Ebi
1 reference
Satoshi Oizumi
1 reference
Koji Takeda
1 reference
Kazuhiko Shibata
1 reference
Hideo Saka
1 reference
Fumio Imamura
1 reference
Nobuhiko Seki
1 reference
Hiroshi Saito
1 reference
Isao Goto
1 reference
Kazuhiko Nakagawa
1 reference
West Japan Oncology Group
1 reference
1 July 2010
1 reference
1 reference
1075-1080
1 reference
Identifiers
1 reference
1 reference